Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
DELRAY BEACH, Fla.--(BUSINESS WIRE)--Digital Angel Corporation (“Digital Angel” or the “Company”) (OTC Markets: DIGA), a provider of implantable medical device identification and radiation dose measurement technologies following its recent share exchange with VeriTeQ Acquisition Corporation (“VeriTeQ”), announced today that it has received its first order for its Q Inside implantable microchip for unique device identification (“UDI”) from Establishment Labs, S.A. (“EL”), the Company’s partner in the breast implant market, for September delivery. EL has received its first order from a customer in the European Union to offer the world’s first traceable breast implant with “Q Inside” to patients. EL has filed for CE mark for its Motiva Implant Matrix® implants with “Q Inside” to be marketed in Europe.
Help employers find you! Check out all the jobs and post your resume.
DELRAY BEACH, Fla.--(BUSINESS WIRE)--Digital Angel Corporation (“Digital Angel” or the “Company”) (OTC Markets: DIGA), a provider of implantable medical device identification and radiation dose measurement technologies following its recent share exchange with VeriTeQ Acquisition Corporation (“VeriTeQ”), announced today that it has received its first order for its Q Inside implantable microchip for unique device identification (“UDI”) from Establishment Labs, S.A. (“EL”), the Company’s partner in the breast implant market, for September delivery. EL has received its first order from a customer in the European Union to offer the world’s first traceable breast implant with “Q Inside” to patients. EL has filed for CE mark for its Motiva Implant Matrix® implants with “Q Inside” to be marketed in Europe.
Help employers find you! Check out all the jobs and post your resume.